Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 9;10(4):662.
doi: 10.3390/jcm10040662.

Changes in Plasma Glial Fibrillary Acidic Protein in Children Receiving Sevoflurane Anesthesia: A Preliminary Randomized Trial

Affiliations

Changes in Plasma Glial Fibrillary Acidic Protein in Children Receiving Sevoflurane Anesthesia: A Preliminary Randomized Trial

Eun-Hee Kim et al. J Clin Med. .

Abstract

We investigated changes in plasma glial fibrillary acidic protein concentration during sevoflurane anesthesia induction in children < 3 years old and determined the effect of co-administering dexmedetomidine. This preliminary randomized trial included 60 pediatric patients who received sevoflurane anesthesia for >3 h. Patients were assigned to dexmedetomidine or control groups at a 1:1 ratio. The primary outcome was changes in plasma glial fibrillary acidic protein concentration of dexmedetomidine and control groups over time. Fifty-five patients were included in the final analysis. The median (interquartile range (IQR)) of the plasma glial fibrillary acidic protein level was 387.7 (298.9-510.8) pg·mL-1 immediately after anesthetic induction, 302.6 (250.9-412.5) pg·mL-1 at 30 min, and 321.9 (233.8-576.2) pg·mL-1 at 180 min after the first sample. These values did not change over time (p = 0.759). However, plasma glial fibrillary acidic protein increased after 180 min of infusion of dexmedetomidine compared with values at 30 min infusion (p = 0.04, mean difference and 95% confidence interval of 221.6 and 2.2 to 441.0 pg·mL-1). In conclusion, three hours of sevoflurane anesthesia in pediatric patients < 3 years old did not provoke neuronal injury assessed by the plasma biomarker. Further studies regarding the effect of prolonged dexmedetomidine infusion on anesthetic neuronal injury are required.

Keywords: dexmedetomidine; general anesthesia; glial fibrillary acidic protein; pediatrics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
CONSORT diagram.
Figure 2
Figure 2
Plasma glial fibrillary acidic protein concentration differences during surgery between the groups.

Similar articles

Cited by

References

    1. Shi Y., Hu D., Rodgers E.L., Katusic S.K., Gleich S.J., Hanson A.C., Schroeder D.R., Flick R.P., Warner D.O. Epidemiology of general anesthesia prior to age 3 in a population-based birth cohort. Paediatr. Anaesth. 2018;28:513–519. doi: 10.1111/pan.13359. - DOI - PMC - PubMed
    1. Cote C.J., Wilson S. Guidelines for Monitoring and Management of Pediatric Patients Before, During, and After Sedation for Diagnostic and Therapeutic Procedures. Pediatrics. 2019;41:26E–52E. doi: 10.1542/peds.2019-1000. - DOI - PubMed
    1. DeFrances C.J., Cullen K.A., Kozak L.J. National Hospital Discharge Survey: 2005 annual summary with detailed diagnosis and procedure data. Vital Health Stat. 2007;13:1–209. - PubMed
    1. Andropoulos D.B., Greene M.F. Anesthesia and Developing Brains—Implications of the FDA Warning. N. Engl. J. Med. 2017;376:905–907. doi: 10.1056/NEJMp1700196. - DOI - PubMed
    1. US Food and Drug Administration Evaluation of Automatic Class III Designation for Banyan Brain Trauma Indicator. [(accessed on 1 July 2019)]; Available online: https://www. accessdata.fda.gov/cdrh_docs/reviews/DEN170045.pdf.

LinkOut - more resources